Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case–control study
- 612 Downloads
The objective of this study was to evaluate the mortality of and risk factors for bacteriuria due to carbapenem-resistant Klebsiella pneumoniae (CRKp) versus carbapenem-susceptible K. pneumoniae (CSKp) producing extended spectrum β lactamase (ESBL).
This was a retrospective case–control study in which 135 case-patients with bacteriuria due to CRKp were compared with 127 control patients with CSKp producing ESBL. In a first step, multivariate Cox regression and Kaplan–Meier survival analysis models were used to determine the difference in mortality between the two groups and risk factors for mortality. In a second step, a univariate analysis was used to identify risk factors for CRKp colonization.
There were no significant demographic or clinical differences between the groups. In-hospital mortality in the study and control groups was 29 and 25 %, respectively (non-significant difference). Multivariate analysis revealed that the most important risk factor for mortality in both groups was being bed ridden [hazard ratio 2.2, 95 % confidence interval (CI) 1.23–3.93; P = 0.008]. Patients with CRKp bacteriuria had a longer hospitalization time with a mean ± standard deviation of 28 ± 33 days compared to 22 ± 28 days in the control group (P < 0.05). Several univariate risk factors for acquiring CRKp bacteriuria were identified: antibiotic use [odds ratio (OR) 1.93, 95 % CI 1.18–3.17, p = 0.008], especially colistin (OR 2.04, 95 % CI 1.04–4.02; P = 0.036), presence of a urinary catheter (OR 2.09, 95 % CI 1.2–3.63; P = 0.008), surgery (OR 3.94, 95 % CI 1.85–8.37; P = 0.0002), invasive procedures (OR 3.06, 95 % CI 1.61–5.8; P = 0.0004), and intensive care unit admission (OR 2.49, 95 % CI 1.18–5.37; P = 0.015).
Bacteriuria caused by CRKp as compared that caused by CSKp was not found to be a risk factor for death.
KeywordsCarbapenem resistance Klebsiella pneumoniae Multi-drug resistance Bacteriuria Urinary tract infection Nosocomial infection
Conflict of interest
- 16.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 19th International supplement. CLSI document M100-S10. Wayne: Clinical Laboratory Standards Institute; 2009.Google Scholar
- 22.Burke JP. Nosocomial urinary tract infections. In: Mayhall CG, editor. Hospital epidemiology infection control. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 267–86.Google Scholar
- 23.Salgavo CD. Prevention of catheter associated urinary tract infection. In: Wenzel RP, editor. Prevention and control of nosocomial infections. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 297–311.Google Scholar